Pharmaceutical Patent-Antitrust: Reverse Payment Settlements and Product Hopping

Thomas, John R.

Library of Congress. Congressional Research Service.

关键词: Drugs;    Drug industry;    Patent law and legislation;    Intellectual property;   

RP-ID  :  R44222
RP-ID  :  R44222_2015Oct07

美国|英语

来源: UNT Digital Library

【 摘 要 】

This report introduces and analyzes innovation and competition policy issues associated with the pharmaceutical industry. It begins with a review of the Hatch-Waxman Act and its implications upon the availability of generic substitutes for brand-name medications. The report then turns to a basic review of the antitrust law. It then addresses judicial developments with respect to reverse payment settlements and product hopping. The report closes with a summary of congressional issues and possible alternatives.